# bluesail+

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bluesail

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Total disclosed funding: $244M
- Latest round: Series B (Sep 23, 2026)
- Investors on record: 5

## About

Based in Beijing, China, and founded in 2019, Beijing Lanfan Baisheng Medical Technology Co., Ltd., trading as bluesail+, operates as a medical device developer dedicated to providing cardiovascular and cerebrovascular treatment equipment. It is a subsidiary of Bluesail Medical. The company integrates entities such as Singapore-based Biosensors International Group (including China’s JW Medical), Germany’s NVT, and the Bluesail Shanghai R&D Center. In September 2026, bluesail+ raised CNY 700 million in Series B funding from CCB Investment Funds Management.

The company's main business is the research, development, production and sales of cardiac stents. Its products include coronary artery graft intervention, valve replacement and repair systems, etc. The products are mainly used to treat cardiovascular and cerebrovascular diseases.

The company generates revenue by providing medical devices used to treat cardiovascular and cerebrovascular diseases, such as heart stents, and other related products.

The Series B funding raised in September 2026 will be used to accelerate product development, commercialization, and market expansion across the company’s cardiovascular medical device portfolio.

## Funding rounds

- Series B, Sep 23, 2026, $104M — CCB Investment Funds Management
- Series A, May 21, 2024, $14M — Beijing New Aerotropolis Fund Management
- Series A, Jan 26, 2024, $126M — Huagai Capital, Linkong Private Equity Fund, Linqu County High-tech Industrial Investment

## Investors

- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- Linkong Private Equity Fund — Series A
- Linqu County High-tech Industrial Investment — Series A
- Beijing New Aerotropolis Fund Management (https://capitalatlas.ai/funds/beijing-new-aerotropolis-fund-management) — Series A
- CCB Investment Funds Management (https://capitalatlas.ai/funds/ccb-investment-funds-management) — Series B